Kevin Dinneen is a Co-Founder at leafie. He focuses on cannabis and psychedelics, exploring their social implications and data trends, particularly in the context of the United Kingdom. Kevin's insights and expertise in these areas have been featured in leafie.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Kevin Dinneen's coverage predominantly focuses on cannabis, drug policy, and health-related scientific research. His articles often involve citing data and referencing government announcements or legal policy regulations.
When reaching out to Kevin, consider providing insights from credible experts in the fields of cannabis research, drug policy analysis, or public health. Additionally, offering access to relevant datasets or discussing the implications of recent government announcements related to these topics could be particularly appealing.
Since there is no specific geographic focus mentioned for Kevin's coverage area, pitches with an international perspective on cannabis legalization policies and scientific findings may be well received by him.
This information evolves through artificial intelligence and human feedback. Improve this profile .
A study of patients living with depression showed a marked decrease in suicidal thoughts and levels of depression after being treated with cannabis.
By: Kevin Dinneen
Data from a study has shown the use of medicinal cannabis can lead to healthier parents who spend more time engaging with their children, improving development.
By: Kevin Dinneen
Researchers in Philadelphia, USA have shown that new medical cannabis patients experience rapid and meaningful improvements in their health-related quality of life after just three months of treatment.
A small Canadian study has found evidence that consuming cannabis can enhance the enjoyment of music
The Cannabis Industry Council has published a good practice guide for prescription cannabis clinics in the UK with the aim of improving patient care.
The number of Canadians buying cannabis from illegal sources has dropped to a record low according to a public health survey.
Patients living with IBD have reported that cannabis medicines can help control symptoms and raise their general quality of life, according to data taken from the UK Medical Cannabis Registry.
By: Kevin Dinneen
Cannabis legalisation in the US has had a “consistent negative relationship” on opioid related deaths, according to new research.
By: Kevin Dinneen
A study of almost 10,000 adolescent brains has shown physical differences in some people may predetermine the likelihood of experimenting with drugs.
Researchers hope cannabis will provide comfort to patients living with late-stage dementia in a first of its kind study.
(833) 317-6278 
